Matthew Borkon, MD
Vascular Surgery · Winchester, VANPI 1972650778
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $9,039 of the $14,972 with a category attached, or 60.4%. Medtronic accounts for 89.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $7,206 and has fallen 86.4% since, to $979 in 2025.
Across 154 payments — averaging $97.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$13K
- Johnson & Johnson$231
- Bolton Medical Inc$211
- Bard Peripheral Vascular, Inc.$196
- Boston Scientific$192
- Silk Road Medical, Inc.$163
- plus $642 from 15 others
What the payments were for
- Travel & lodging$9,03960%
- Food & beverage$5,93440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 114 | $13,337 |
| Johnson & Johnson | 5 | $231 |
| Bolton Medical Inc | 4 | $211 |
| Bard Peripheral Vascular, Inc. | 2 | $196 |
| Boston Scientific | 2 | $192 |
| Silk Road Medical, Inc. | 4 | $163 |
| W. L. Gore & Associates, Inc. | 1 | $116 |
| Shape Memory Medical Inc. | 2 | $73 |
| Artivion, Inc. | 1 | $72 |
| Cook Medical LLC | 3 | $57 |
| Tactile Systems Technology Inc | 3 | $57 |
| Zimmer Biomet | 1 | $46 |
| Integra Lifesciences Corporation | 2 | $38 |
| Stryker | 1 | $38 |
| Lemaitre Vascular, Inc. | 2 | $31 |
| Smith+Nephew | 2 | $31 |
| Surmodics, Inc. | 1 | $24 |
| Angiodynamics, Inc. | 1 | $22 |
| Cvrx, Inc. | 1 | $18 |
| Amgen | 1 | $16 |
| Reflow Medical Inc | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,972 in reported general payments places this provider in the 65th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $16,081 |
| ClopidogrelClopidogrel Bisulfate | 194 | $1,202 |
| Atorvastatin Calcium | 72 | $403 |
| Methylprednisolone | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Winchester
- Mark KumarWinchester$37K
- Jean PannetonVirginia Beach$1.3M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
- Joshua AdamsRoanoke$138K
- Richard NevilleFalls Church$114K
- Anthony ComerotaFalls Church$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.